Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
1.
Environ Res ; 263(Pt 1): 120015, 2024 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-39284485

RESUMO

Monitoring water quality and river ecosystems is vital for maintaining public health and environmental sustainability. Over the past decade, data-driven methods have been extensively used for river water quality modeling, including dissolved oxygen (DO) concentrations. Despite advancements, challenges persist regarding accuracy, scalability, and adaptability of data-driven models to diverse environmental conditions. Previous studies primarily employed singular models or basic combinations of machine learning techniques, lacking advanced integration of adaptive mechanisms to process complex and evolving datasets. The current study introduces innovative hybrid models that integrate temporal pattern attention (TPA) mechanisms with advanced neural networks, including feed-forward neural networks (FFNNs) and long short-term memory networks (LSTMs). This approach leverages the synergistic strengths of individual models, significantly enhancing the accuracy of DO predictions. The models were rigorously tested against water quality data obtained from two distinct riverine environments, the Illinois River (ILL) and Des Plaines River (DP). Daily measured water quality data, including DO, chlorophyll-a, nitrate plus nitrite, water temperature, specific conductance, and pH, from 2017 to 2024 provided a robust foundation for comprehensive analysis of DO dynamics in these rivers. We conducted 10 scenarios with different model inputs, wherein the hybrid TPACWRNN-LSTM-10 model particularly excelled, achieving coefficient of determination values of 0.993 and 0.965, and root mean squared errors of 0.241 mg/L and 0.450 mg/L for DO predictions at the ILL and DP stations, respectively. The model's reliability was further confirmed by Willmott's index values of 0.998 and 0.992 and Nash-Sutcliffe efficiency values of 0.990 and 0.961 at the ILL and DP stations, respectively. Additionally, Shapley additive explanations (SHAP) values were utilized to interpret each predictor's contribution, revealing key drivers of DO predictions. We believe the novel hybrid modeling approach presented in this study could benefit utilities and water resource management systems for predicting water quality in complex systems.

2.
Biomark Med ; 18(15-16): 685-693, 2024 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-39263799

RESUMO

Background: Long non-coding (lnc) RNAs have crucial regulatory roles in molecular pathways, and their dysregulation is associated with the pathogenesis of malignancies such as Diffuse large B-cell lymphoma (DLBCL). Therefore, we aimed to study the NEAT1 and CHROMR expression in DLBCL and explore their association with clinicopathological characteristics.Methods & materials: DLBCL and non-tumor lymph node specimens were obtained to assess the expression levels.Results: NEAT1 and CHROMR expressions were significantly increased in DLBCL, and were linked with the age of DLBCL patients (aged >60). NEAT1 and CHROMR overexpression may serve as moderate-to-good diagnostic biomarkers, with NEAT1 and CHROMR exhibiting area under the curve values of 0.781 and 0.831, respectively.


[Box: see text].


Assuntos
Biomarcadores Tumorais , Linfoma Difuso de Grandes Células B , RNA Longo não Codificante , Humanos , RNA Longo não Codificante/genética , RNA Longo não Codificante/metabolismo , Linfoma Difuso de Grandes Células B/genética , Linfoma Difuso de Grandes Células B/diagnóstico , Linfoma Difuso de Grandes Células B/metabolismo , Linfoma Difuso de Grandes Células B/patologia , Masculino , Idoso , Feminino , Pessoa de Meia-Idade , Biomarcadores Tumorais/genética , Biomarcadores Tumorais/metabolismo , Adulto , Regulação Neoplásica da Expressão Gênica , Idoso de 80 Anos ou mais , Prognóstico , Curva ROC
3.
Artigo em Inglês | MEDLINE | ID: mdl-39177783

RESUMO

Breast cancer (BC) is the second most common malignancy worldwide. ADGRL4, as a modulator of angiogenesis, undergoes various epigenetic modifications affecting its biological functions. In this study, we aimed to assess ADGRL4 promoter methylation status and its expression levels in primary breast tumors and to evaluate its potency as a plausible prognostic biomarker in BC. Furthermore, we evaluated the effect of melatonin on ADGRL4 expression and viability of BC cells in vitro. One hundred breast tumor tissue samples and adjacent non-tumor tissues were collected, followed by DNA isolation, bisulfite conversion, qRT-PCR, qMSP assay, and immunoblotting. In addition, four BC cell lines were treated with melatonin and subjected to ADGRL4 expression analysis and apoptosis assay. We found a significant correlation between ADGRL4 expression levels and HER2 status and stage of disease (P < 0.05). We observed a substantial attenuation in ADGRL4 promoter methylation in tumor samples compared to marginal non-tumor samples. A significantly lower expression of ADGRL4 was detected in two BC cell lines in the presence of melatonin. MCF-7 and BT474 melatonin-treated cell lines showed a significantly higher number of apoptotic cells than non-treated cells (P < 0.0001). Based on the receiver operating characteristic (ROC) curve analysis, ADGRL4 expression and ADGRL4 promoter methylation status showed moderate prognostic value. We found that melatonin has anti-cancer effects on BC cells. In addition, ADGRL4 expression can potentially be used as a prognostic biomarker in BC.

4.
Sci Total Environ ; 913: 169297, 2024 Feb 25.
Artigo em Inglês | MEDLINE | ID: mdl-38103616

RESUMO

Inter-basin water diversion (IBWD) is a viable strategy to tackle water scarcity and quality degradation due to climate change and increasing water demand in headwaters regions. Nevertheless, the capacity of IBWD to mitigate the impacts of climate change on water quality has rarely been quantified, and the underlying processes are not well understood. Therefore, this study aims to elucidate how the IBWD manipulated total phosphorus (TP) loading dilution and conveying patterns under climate change and determine a critical threshold for the quantity of water entering downstream reservoirs (WIN) for operational scheduling. To resolve this issue, climate-driven hydrologic variability over a 60-year period was derived utilizing the least square fitting approach. Subsequently, six scenarios evaluating the response of in-lake TP concentrations (TPL) to increased temperatures and IBWDs of 50 %, 100 %, and 150 % from the baseline water volume in 2030 and 2050 were studied by employing a calibrated hydrological-water quality model (SWAT-YRWQM). In the next stage, three datasets derived from mathematical statistics based on the observed data, the Vollenweider formula, and modeled projections were integrated to formulate best management practices. The results revealed that elevated air temperatures would lead to reduced annual catchment runoff but increased IBWD. Additionally, our study quantified the IBWD potential for mitigating water quality degradation, indicating the adverse effects of climate change on TPL would be weakened by 4.2-14.4 %. A critical threshold for WIN was also quantified at 617 million m3, maintaining WIN at or near 617 million m3 through optimized operational scheduling of IBWD could effectively restrict external inflow TP loading to lower levels. This study clearly illustrates the intricate interactive effects of climate change and IBWD on aquatic environments. The methodology elucidated in this study for determining the critical threshold of WIN could be applied in water management for analogous watershed-receiving waterbody systems.

5.
Front Oncol ; 13: 1132514, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37064148

RESUMO

Background: Artificial intelligence (AI) discrimination models using single radioactive variables in recognition algorithms of lung nodules cannot predict lung cancer accurately. Hence, we developed a clinical model that combines AI with blood test variables to predict lung cancer. Methods: Between 2018 and 2021, 584 individuals (358 patients with lung cancer and 226 individuals with lung nodules other than cancer as control) were enrolled prospectively. Machine learning algorithms including lasso regression and random forest (RF) were used to select variables from blood test data, Logistic regression analysis was used to reconfirm the features to build the nomogram model. The predictive performance was assessed by performing the receiver operating characteristic (ROC) curve analysis as well as calibration, clinical decision and impact curves. A cohort of 48 patients was used to independently validate the model. The subgroup application was analyzed by pathological diagnosis. Findings: A total of 584 patients were enrolled (358 lung cancers, 61.30%,226 patients for the control group) to establish the model. The integrated model identified eight potential factors including carcinoembryonic antigen (CEA), AI score, Pro-Gastrin Releasing Peptide (ProGRP), cytokeratin 19 fragment antigen21-1(CYFRA211), squamous cell carcinoma antigen(SCC), indirect bilirubin(IBIL), activated partial thromboplastin time(APTT) and age. The area under the curve (AUC) of the nomogram was 0.907 (95% CI, 0.881-0.929). The decision and clinical impact curves showed good predictive accuracy of the model. An AUC of 0.844 (95% CI, 0.710 - 0.932) was obtained for the external validation group. Conclusion: The nomogram model integrating AI and clinical data can accurately predict lung cancer, especially for the squamous cell carcinoma subtype.

6.
Theriogenology ; 205: 40-49, 2023 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-37084502

RESUMO

This study was designed to investigate the roles of melatonin administration during different sensitive windows of the first half of pregnancy in the function and gene expression of the ovary and placenta, hormone profile, and pregnancy outcomes in rabbits. Four equal experimental groups of 20 rabbits each were used. The first (FW), second (SW), and third (F + SW) groups comprised rabbits that orally received 0.7-mg melatonin/kg body weight during the first week, second weeks, and during both weeks of pregnancy; and the fourth group served as the control group (C). The total number of visible follicles significantly increased in all melatonin-treated groups compared with that in the C group. In all melatonin-treated groups, the number of absorbed fetuses was significantly reduced, whereas the weights of embryonic sacs and fetuses were higher than in the C group. The placenta efficiency was significantly increased in the F + SW group compared with that in the C group, followed by the SW group, whereas no significant difference in the placenta efficiency was found between the FW and C groups. Melatonin treatments significantly improved the expression of antioxidants, gonadotropin receptors, and cell cycle regulatory genes in the ovary, whereas only FW treatment upregulated steroidogenic acute regulatory gene. Compared with the C and FW groups, melatonin treatments during the SW and F + SW significantly upregulated the expression of most genes in the placenta. The concentrations of estradiol were significantly higher in the SW and F + SW groups than in the FW and C groups. The concentrations of progesterone were significantly increased in the FW group compared with those in the C and SW groups, whereas the F + SW group showed intermediate values. The litter size and weight at birth significantly increased in all melatonin-treated groups compared with those in the C group. The second week of pregnancy seems to be a sensitive window for melatonin actions during pregnancy. Thus, melatonin administration during the second week of pregnancy can be effective in improving pregnancy outcomes in rabbits.


Assuntos
Melatonina , Gravidez , Coelhos , Feminino , Animais , Ovário , Placenta/metabolismo , Parto , Resultado da Gravidez
7.
J Adv Med Educ Prof ; 11(1): 42-49, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36685147

RESUMO

Introduction: Professionalism, as one of the core competencies of physicians, is essential for providing the patients with higher quality care. It is an abstract concept and its education and assessment need objective and operational methods. The present study aimed at teaching the concepts of professionalism based on a scenario-based approach using role-playing and reflection. Methods: This is a pre-experimental study (one-group pretest-posttest design) with a mixed method approach. The study was conducted on 18 medical students (by voluntary sampling method) who had enrolled in the Medical Ethics Course at Kashan University of Medical Sciences in 2020. Twelve scenarios were designed about the most prevalent issues of medical professionalism. In each session, one group of students played out their scenarios and then, the participants and instructors discussed their role-playing. Participants' knowledge about professionalism was assessed at the beginning and end of each session, and they completed a satisfaction questionnaire and a reflection form. T-tests (one-sample and paired T-test) were applied for statistical analysis. Quantitative and qualitative data were analyzed using SPSS software (version 26), and P<0.05 was considered statistically significant. Conventional content analysis was used to analyze the qualitative data. Results: The mean scores of the participants' knowledge in post-test were significantly higher than those in the pre-test (P=0.042, t=-2.074). The mean scores of the participants' role-playing quality (p<0.001) and satisfaction (p=0.001) were significantly higher than their corresponding test values. Qualitative analysis of the participants' reflections revealed their satisfaction with the study intervention. Conclusion: The scenarios, role-playing, and reflection could provide an opportunity for operationalizing the concepts of professionalism and deep learning of students. Medical instructors need to improve their knowledge and skills of using active methods in teaching professionalism to medical students.

8.
Genes Cancer ; 13: 52-59, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36471781

RESUMO

AIM: Cervical cancer (CC) is one of the most common cancers in women. Recent advances in screening and vaccination against the papilloma virus (HPV) have increased protection against CC. However, there is no effective diagnostic biomarker and treatment approach during the course of the disease. The current study is thus aimed to evaluate the changes in the expression of lncRNA associated with microvascular invasion in hepatocellular carcinoma (lncRNA MVIH) and its diagnostic value as a biomarker in CC patients. MATERIALS AND METHODS: One-hundred and fifteen (n = 115) pairs of CC primary tumor and marginal non-tumor tissue samples were obtained from Tabriz Valiasr International Hospital (Tabriz, Iran). RNA extraction and cDNA synthesis followed by quantitative reverse transcriptase PCR (qRT-PCR) were considered to investigate alterations in the expression levels of MVIH in patients with CC. The associations between MVIH expression changes and clinicopathological features as well as its potential as a diagnostic biomarker were assessed using SPSS and GraphPad prism software and the receiver operating characteristic (ROC). RESULTS: The expression levels of MVIH were significantly higher in CC tumors as compared to marginal non-tumor samples (p < 0.0001). Overexpression of MVIH was significantly associated with younger age (p = 0.033), lymph node metastasis (p = 0.031), tumor invasion depth (p = 0.035), and squamous cell type of CC (p = 0.019). The ROC analysis for MVIH as a diagnostic biomarker revealed the respective sensitivity and specificity of 67.83 and 80. CONCLUSIONS: Overexpression of MVIH in CC tumors suggests its oncogenic role during tumorigenesis. Thus, it may serve as a potential diagnostic biomarker.

9.
Artigo em Inglês | MEDLINE | ID: mdl-35580209

RESUMO

In the current study, the expression levels of two important lncRNAs, i.e., AK058003 and APOC1P1, in breast tumors were compared with adjacent non-tumor tissues to evaluate their diagnostic potential in a panel of 121 patients. Total RNA was extracted, cDNA was synthesized and expression of AK058003 and APOC1P1 was assessed using qRT-PCR. A significant overexpression and positive correlation between these two lncRNAs were observed in tumor tissues compared to marginal healthy tissues. In conclusion, the examined lncRNAs were overexpressed in tumor tissues, suggesting their significant diagnostic value in breast cancer.


Assuntos
Neoplasias da Mama , RNA Longo não Codificante , Neoplasias da Mama/diagnóstico , Neoplasias da Mama/genética , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , RNA Longo não Codificante/genética , RNA Longo não Codificante/metabolismo
10.
Sci Rep ; 12(1): 5846, 2022 04 07.
Artigo em Inglês | MEDLINE | ID: mdl-35393477

RESUMO

The medicinal potential of marine invertebrates' bioactive components that may act as anti-COVID-19 demonstrated promising results. Ophiocoma dentata, which is common in the Red Sea, is one such source. Therefore, this study aimed to isolate a new compound from the brittle star, Ophiocoma dentata, and evaluate its efficacy as anti-COVID-19 in-silico and in-vitro. Standard procedures were followed in order to assess the isolated compound's preliminary toxicity and anti-inflammatory properties. Computer virtual screening technology through molecular docking and ADMET studies was conducted as well as a new steroid derivative was isolated for the first time, named 5α-cholesta-4(27), 24-dien-3ß, 23 ß-diol. Investigation of the Anti-Covid-19 activity of the isolated compound using a Plaque reduction assay revealed 95% inhibition at a concentration of 5 ng/µl (12.48 µM). Moreover, this compound showed an IC50 of 11,350 ± 1500 ng/ml against the normal fibroblast cells, indicating its safety. Interestingly, this compound exhibited anti-inflammatory activity with an IC50 of 51.92 ± 0.03 µg/ml compared to a reference drug's IC50 of 53.64 ± 0.01 µg/ml, indicating that this compound is a potent anti-inflammatory. In silico data have proved that the isolated compound is a promising viral inhibitor against SARS-CoV2 and is thus recommended as a future nature preventive and curative antiviral drug.


Assuntos
Tratamento Farmacológico da COVID-19 , Anti-Inflamatórios/farmacologia , Humanos , Simulação de Acoplamento Molecular , RNA Viral , SARS-CoV-2 , Esteroides
11.
J Gastrointest Cancer ; 53(3): 687-691, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34478035

RESUMO

PURPOSE: Gastric cancer (GC) is one of the most frequent tumors worldwide and identification of a sensitive and specific prognostic biomarker is of great importance. Long non-coding RNAs (lncRNAs) play crucial roles in tumorigenesis of various malignancies. In the present study, we investigated lncRNA FOXD2-AS1 expression in gastric tumors and assessed its potential as a prognostic biomarker. METHODS: A total of 95 tumor and corresponding adjacent non-tumor tissue specimens were collected from patients with GC from Imam Reza hospital, Tabriz, Iran. Total RNA was isolated and FOXD2-AS1 expression was measured using quantitative reverse transcriptase (qRT)-PCR. RESULTS: FOXD2-AS1 was significantly upregulated in tumor samples as compared to non-tumor tissues (P < 0.0001). In addition, higher expression of FOXD2-AS1 was significantly associated with lymph node metastasis and Helicobacter pylori infection. The receiver operating characteristic (ROC) curve analysis revealed that FOXD2-AS1 might be served as a potential prognostic biomarker for GC. CONCLUSION: FOXD2-AS1 is upregulated in gastric tumors and can be used as a valuable biomarker in the prognosis of patients with GC.


Assuntos
Infecções por Helicobacter , Helicobacter pylori , RNA Longo não Codificante , Neoplasias Gástricas , Linhagem Celular Tumoral , Proliferação de Células/genética , Regulação Neoplásica da Expressão Gênica , Infecções por Helicobacter/complicações , Infecções por Helicobacter/genética , Helicobacter pylori/genética , Humanos , Prognóstico , RNA Longo não Codificante/metabolismo , Neoplasias Gástricas/genética , Neoplasias Gástricas/patologia
12.
J Gastrointest Cancer ; 53(4): 1014-1019, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34766250

RESUMO

PURPOSE: Gastric cancer (GC) is a heterogeneous disease, and this heterogeneity significantly affects survival and treatment outcomes. Identification of molecular biomarkers specific for early-stage GC can help clinicians to choose more precise and effective treatment approaches. Long non-coding RNAs (lncRNAs) have the potential to be used as biomarkers because of their tissue specificity, stability, and availability in body fluids. In this study, we aimed to investigate changes in the expression levels of lncRNA KRT18P55 and to assess its biomarker potentials in patients with GC. METHODS: Tumor and non-tumor marginal tissues were collected from 102 patients at Noor-Nejat Hospital (Tabriz, Iran). RNA was isolated, and quantitative reverse transcriptase PCR (qRT-PCR) was performed to assess KRT18P55 expression levels in tumor and non-tumor tissue samples. The receiver operating characteristic (ROC) curve analysis was performed to evaluate potentials of KRT18P55 as a prognostic biomarker in GC. SPSS and GraphPad Prism software were used for data analysis. RESULTS: We found that KRT18P55 is significantly overexpressed in tumor as compared to non-tumor tissues (p < 0.0001). We found a significant association between KRT18P55 overexpression and intestinal GC subtype (p < 0.0001), lymph node metastasis (p = 0.013), and Helicobacter pylori infection (p = 0.033). Based on the ROC analysis, KRT18P55 showed a sensitivity and specificity of 53.92% and 77.45%, respectively. CONCLUSION: Overexpression of KRT18P55 in gastric tumors is suggestive of its oncogenic role in GC. In addition, KRT18P55 may be used as a potential prognosis biomarker and therapeutic target in intestinal GC subtype.


Assuntos
RNA Longo não Codificante , Neoplasias Gástricas , Humanos , Biomarcadores Tumorais/genética , Infecções por Helicobacter , Prognóstico , RNA Longo não Codificante/genética , Neoplasias Gástricas/genética , Neoplasias Gástricas/patologia
14.
Biomed Pharmacother ; 143: 112190, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34560543

RESUMO

Brain metastasis (BM) is the most common event in patients with lung cancer. Despite multimodal treatments and advances in systemic therapies, development of BM remains one of the main factors associated with poor prognosis and mortality in patients with lung cancer. Therefore, better understanding of mechanisms involved in lung cancer brain metastasis (LCBM) is of great importance to suppress cancer cells and to improve the overall survival of patients. Several cancer-related genes such as EGFR and KRAS have been proposed as potential predictors of LCBM. In addition, there is ample evidence supporting crucial roles of non-coding RNAs (ncRNAs) in mediating LCBM. In this review, we provide comprehensive information on risk assessment, predictive, and prognostic panels for early detection of BM in patients with lung cancer. Moreover, we present an overview of LCBM molecular mechanisms, cancer driver genes, and ncRNAs which may predict the risk of BM in lung cancer patients. Recent clinical studies have focused on determining mechanisms involved in LCBM and their association with diagnosis, prognosis, and treatment outcomes. These studies have shown that alterations in EGFR, KRAS, BRAF, and ALK, as the most frequent coding gene alterations, and dysregulation of ncRNAs such as miR-423, miR-330-3p, miR-145, piR-651, and MALAT1 can be considered as potential biomarkers of LCBM.


Assuntos
Biomarcadores Tumorais/genética , Neoplasias Encefálicas/genética , Variação Genética , Neoplasias Pulmonares/genética , RNA não Traduzido/genética , Animais , Biomarcadores Tumorais/metabolismo , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/secundário , Regulação Neoplásica da Expressão Gênica , Humanos , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patologia , Valor Preditivo dos Testes , Prognóstico , RNA não Traduzido/metabolismo , Medição de Risco , Fatores de Risco , Transdução de Sinais
15.
J Pharm Investig ; 51(6): 735-757, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34513113

RESUMO

Purpose: A novel coronavirus (COVID-19) that has not been previously identified in humans and has no specific treatment has recently spread. Treatment trials using antiviral and immune-modulating drugs such as hydroxychloroquine (HCQ) were used to control this viral outbreak however several side effects have emerged. Berberine (BER) is an alkaloid that has been reported to reveal some pharmacological properties including antioxidant and antimicrobial activities. Additionally, Zinc oxide nanoparticles (ZnO-NPs) possess potent antioxidant and anti-inflammatory properties. Therefore, this study was undertaken to estimate the efficiency of both BER and synthetic ZnO/BER complex as an anti-COVID-19 therapy. Methods: First, the ZnO/BER complex was prepared by the facile mixing method. Then in vitro studies on the two compounds were conducted including VeroE6 toxicity, anti-COVID-19 activity, determination of inhibitory activity towards papain-like proteinase (PL pro) and spike protein- and receptor- binding domain (RBD) as well as assessment of drug toxicity on RBCs. Results: The results showed that ZnO/BER complex acts as an anti-COVID-19 by inhibiting spike protein binding with angiotensin-converting enzyme II (ACE II), PL pro activity, spike protein and E protein levels, and expression of both E-gene and RNA dependent RNA polymerase (RdRp) at a concentration lower than that of BER or ZnO-NPs alone. Furthermore, ZnO/BER complex had antioxidant and antimicrobial properties where it prevents the auto oxidation of 2,2-Diphenyl-1-picrylhydrazyl (DPPH) and the culture of lower respiratory system bacteria that affected Covid 19 patients. The ZnO/BER complex prevented as well the HCQ cytotoxic effect on both RBC and WBC (in vitro) and hepatotoxicity, nephrotoxicity and anemia that occurred after HCQ long administration in vivo. Conclusion: The ZnO/BER complex can be accounted as promising anti-COVID 19 candidate because it inhibited the virus entry, replication, and assembly. Furthermore, it could be used to treat a second bacterial infection that took place in hospitalized COVID 19 patients. Moreover, ZnO/BER complex was found to eliminate the toxicity of long-term administration of HCQ in vivo.

16.
Environ Sci Pollut Res Int ; 28(37): 51369-51383, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-33982260

RESUMO

The present study attempts to assess the threat of water contamination in Persian Gulf by heavy metals (Fe, Cr, Pb, Cu, Zn, Cd, Se, and Ni) and its subsequent effects on five fish species including Scomberomorus guttatus (S. guttatus), Lethrinus nebulosus (L. nebulosus), Brachirus orientalis (B. orientalis), Pomadasys kaakan (P. kaakan), and Scomberomorus commerson (S. commerson). Water and fish samples from fourteen monitoring stations were obtained to determine the concentrations of contaminants in water and fish. Heavy metal pollution index (HMPI) and non-carcinogenic hazard quotient (NHQI) were employed to evaluate contamination level in water and fish muscle. The Kriging geostatistical method was employed to determine the spatial distribution of different heavy metals around petrochemical plants. The highest NHQI values for P. kaakan and B. orientalis species were 1.036 and 1.046, respectively. In both cases, the NHQI values were higher than the maximum allowable value of 1, indicating that both fish species were on the verge of contamination by heavy metals, which in turn makes the consumption of these fish highly hazardous to human health. The lowest NHQI value was observed in S. commerson species at a value of 0.394, indicating its harmlessness to human health. Overall, fish species living within the top 5 m of the water column (S. commerson and S. guttatus) were found to be less contaminated by heavy metals compared to species dwelling near the seafloor (P. kaakan and B. orientalis). Results also indicated the pollution absorption rate in S. commerson and S. guttatus were 0.45 and 3.4 mg/kg-year, while the corresponding values for the B. orientalis and L. nebulosus species were 6 and 2 mg/kg-year, respectively. P. kaakan species showed a pollution absorption rate of 3.2 mg/kg-year. High heavy metal concentrations of 4.8, 10, 9.8, 5.2, 9.4, and 6.7 mg/L were obtained for Cr, Zn, Pb, Ni, Fe, Cu, and Cd, respectively, in water samples obtained from stations nearby petrochemical plants. The HMPI index for the most contaminated stations was ten times that of the maximum allowable limit. Given the intense activity of oil, gas, and petrochemical plants in the Persian Gulf, defining safe fishing areas by management practices similar to contamination zoning maps presented in this study can substantially protect the public health from heavy metal contamination.


Assuntos
Metais Pesados , Poluentes Químicos da Água , Animais , Monitoramento Ambiental , Humanos , Metais Pesados/análise , Plantas , Medição de Risco , Poluentes Químicos da Água/análise , Qualidade da Água
17.
Curr Stem Cell Res Ther ; 16(7): 877-887, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33563177

RESUMO

BACKGROUND: Cancer stem cells (CSCs) are a small subpopulation of cells within tumors and play significant roles in tumorigenesis, metastasis, resistance to treatment, and relapse. They are defined by self-renewal and multi-lineage differentiation, and aggressiveness. Epigenetic modifications, including DNA methylation and acetylation, histone modifications, and non-coding. RNAs (ncRNAs), are partly responsible for CSC potentials and are involved in the modification of key components of crucial pathways such as Notch and Wnt signaling in breast cancer. OBJECTIVE: In this review, we present an overview of the pathways and epigenetic events that lead to the transformation of mammary gland stem cells to breast CSCs (BCSCs). Based on the data presented here, important pathways such as TGF-ß/SMAD2 and Wnt/ß-catenin and epigenetic modifications, including histone modifications, DNA methylations, and microRNAs, play important roles in BCSC formation and maintenance. CONCLUSION: Epigenetic events can alter the expression of genes and functional RNAs, resulting in tumor initiation and progression. Thus, a better understanding of epigenetic modifications involved in BCSC maintenance signaling pathways may help to eliminate or suppress BCSCs and overcome cancer by generating more effective and efficient therapeutic agents.


Assuntos
Neoplasias da Mama , Epigênese Genética , Células-Tronco Neoplásicas , Neoplasias da Mama/genética , Feminino , Humanos , Glândulas Mamárias Humanas/citologia , Recidiva Local de Neoplasia , Transdução de Sinais
18.
Cancers (Basel) ; 12(10)2020 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-33019710

RESUMO

The number of genomic aberrations known to be relevant in making therapeutic decisions for non-small cell lung cancer patients has increased in the past decade. Multiple molecular tests are required to reliably establish the presence of these aberrations, which is challenging because available tissue specimens are generally small. To optimize diagnostic testing, we developed a transcriptome-based next-generation sequencing (NGS) assay based on single primed enrichment technology. We interrogated 11 cell lines, two patient-derived frozen biopsies, nine pleural effusion, and 29 formalin-fixed paraffin-embedded (FFPE) samples. All clinical samples were selected based on previously identified mutations at the DNA level in EGFR, KRAS, ALK, PIK3CA, BRAF, AKT1, MET, NRAS, or ROS1 at the DNA level, or fusion genes at the chromosome level, or by aberrant protein expression of ALK, ROS1, RET, and NTRK1. A successful analysis is dependent on the number of unique reads and the RNA quality, as indicated by the DV200 value. In 27 out of 51 samples with >50 K unique reads and a DV200 >30, all 19 single nucleotide variants (SNVs)/small insertions and deletions (INDELs), three MET exon 14 skipping events, and 13 fusion gene transcripts were detected at the RNA level, giving a test accuracy of 100%. In summary, this lung-cancer-specific all-in-one transcriptome-based assay for the simultaneous detection of mutations and fusion genes is highly sensitive.

19.
Recent Pat Anticancer Drug Discov ; 15(4): 329-340, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32990541

RESUMO

BACKGROUND: The Notch signaling pathway has a key role in angiogenesis and Delta - Like Ligand 4 (DLL4) is one of the main ligands of Notch involved in cell proliferation in sprouting vessels. OBJECTIVE: In this study, we aimed to evaluate the expression of DLL4 in primary breast tumors and to examine the effect of melatonin on DLL4 expression in vitro. METHODS: Eighty-five breast tumor and paired adjacent non-tumor tissue samples were collected. Apoptosis assay was performed on breast cancer cells to evaluate melatonin effects. Western blot and quantitative RT-PCR were used to measure DLL4 expression. Then, we investigated the effect of melatonin on the expression of DLL4 in four breast cancer cell lines at RNA and protein levels. We also performed a probabilistic neural network analysis to study genes closely associated with DLL4 expression. RESULTS: Our results showed a significantly higher expression of DLL4 in tumor tissues compared to non-tumor tissues (P = 0.027). Melatonin treatment substantially attenuated DLL4 expression in BT474 and MCF-7 cells, but not in SK-BR-3 and MDA-MB-231 cells. Also, melatonin induced apoptosis in all four cell lines. Network analysis revealed a set of 15 genes that had close association and interaction with DLL4. DLL4 was overexpressed in breast cancer tissues as compared to the non-tumor tissues. CONCLUSION: It can be concluded that melatonin treatment attenuated DLL4 expression only in estrogen- responsive breast cancer cells and is able to induce apoptosis in breast cancer cells.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Antineoplásicos/farmacologia , Biomarcadores Tumorais/metabolismo , Neoplasias da Mama/tratamento farmacológico , Proteínas de Ligação ao Cálcio/metabolismo , Estrogênios/metabolismo , Melatonina/farmacologia , Proteínas Adaptadoras de Transdução de Sinal/antagonistas & inibidores , Antioxidantes/farmacologia , Apoptose , Neoplasias da Mama/metabolismo , Neoplasias da Mama/patologia , Proteínas de Ligação ao Cálcio/antagonistas & inibidores , Linhagem Celular Tumoral , Proliferação de Células , Feminino , Humanos , Pessoa de Meia-Idade , Patentes como Assunto , Transdução de Sinais
20.
Biochem Pharmacol ; 178: 114095, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32535106

RESUMO

Several different mechanisms are implicated in the resistance of lung cancer cells to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), and only few have been functionally investigated. Here, using genetically knocked out EGFR and TKI-resistant lung cancer cells, we show that loss of wild-type EGFR attenuates cell proliferation, migration and 3D-spheroid formation, whereas loss of mutant EGFR or resistance to TKIs reinforces those processes. Consistently, disruption of wild-type EGFR leads to suppression of HER2/HER3, while mutant EGFR ablation or resistance to TKIs increases HER2/HER3 expression, compensating for EGFR loss. Furthermore, HER2/HER3 nuclear translocation mediates overexpression of cyclin D1, leading to tumor cell survival and drug resistance. Cyclin D1/CDK4/6 inhibition resensitizes erlotinib-resistant (ER) cells to erlotinib. Analysis of cyclin D1 expression in patients with non-small cell lung carcinoma (NSCLC) showed that its expression is negatively associated with overall survival and disease-free survival. Our results provide biological and mechanistic insights into targeting EGFR and TKI resistance.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/genética , Ciclina D1/genética , Regulação Neoplásica da Expressão Gênica , Neoplasias Pulmonares/genética , Receptor ErbB-2/genética , Receptor ErbB-3/genética , Antineoplásicos/uso terapêutico , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/mortalidade , Carcinoma Pulmonar de Células não Pequenas/patologia , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Ciclina D1/metabolismo , Quinase 4 Dependente de Ciclina/genética , Quinase 4 Dependente de Ciclina/metabolismo , Quinase 6 Dependente de Ciclina/genética , Quinase 6 Dependente de Ciclina/metabolismo , Resistencia a Medicamentos Antineoplásicos/genética , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Receptores ErbB/deficiência , Receptores ErbB/genética , Cloridrato de Erlotinib/uso terapêutico , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/mortalidade , Neoplasias Pulmonares/patologia , Inibidores de Proteínas Quinases/uso terapêutico , Receptor ErbB-2/metabolismo , Receptor ErbB-3/metabolismo , Transdução de Sinais , Esferoides Celulares/efeitos dos fármacos , Esferoides Celulares/metabolismo , Esferoides Celulares/patologia , Análise de Sobrevida , Ativação Transcricional
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA